September 2026
The U.S. over the counter (OTC) drugs market size stood at USD 26 billion in 2026, with major U.S. over the counter (OTC) drugs companies including bayer ag, Pfizer, johnson & johnson services inc, Sanofi sa, Novartis ag.
September 2026
The global over the counter (OTC) drugs market size is expected to increase from USD 141.86 billion in 2026 and is expected to hit USD 256.87 billion by 2035, growing at a CAGR of 6.62%
September 2026
The global over-the-counter (OTC) analgesics market size was valued USD 33.07 billion in 2026 and is estimated to hit around USD 45.77 billion by 2035 with a CAGR of 3.68%.
March 2026
The global over the counter (OTC) test market size is estimated to hit around USD 69.23 billion by 2035 increasing from USD 27.41 billion in 2026, with a CAGR of 10.86%.
September 2026
The U.S. digital therapeutics market size is exhibited at USD 4.56 billion in 2026 and is predicted to surpass USD 24.09 billion by 2035 with a remarkable CAGR of 20.54%.
September 2026
The global synthetic lethality-based drugs and targets market size was evaluated at USD 2.19 billion in 2026 and is predicted to hit around USD 9.37 billion by 2035, growing at a CAGR of 17.52%.
September 2026
The over the top (OTT) market size is accounted at USD 503.29 billion in 2026 and is projected to surpass around USD 2816.85 billion by 2034 with a CAGR of 24.42%.
September 2026
The global immunotherapy drugs market size was valued at USD 376.22 billion in 2026 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
September 2026
The global automotive OTA (over-the-air) enablement component market size is estimated to hit around USD 15.94 billion by 2035 increasing from USD 5.41 billion in 2026, with a CAGR of 12.75%.
September 2026
The anesthesia drugs market generated USD 7.92 billion in 2026, with prominent anesthesia drugs market companies including Envigo, JANVIER LABS, Taconic Biosciences Inc.
September 2026
The global atherosclerosis drugs market size is projected to hit around USD 25.07 billion by 2035, increasing from USD 18.24 billion in 2026, with a CAGR of 3.60%.
September 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.83 billion in 2026, with a CAGR of 9.70%.
September 2026
The global power over ethernet chipsets market size was evaluated at USD 1.11 billion in 2026 and is predicted to hit around USD 3.14 billion by 2035, growing at a CAGR of 12.24%.
September 2026
The global power over Ethernet market size is expected to increase from USD 1.83 billion in 2026 to hit around USD 4.87 billion by 2035, growing at a CAGR of 11.50%.
September 2026
The U.S. brachytherapy market was worth USD 370.79 million in 2026, with key U.S. brachytherapy market players including Becton Dickinson & Co, Eckert & Ziegler Bebig SA, Elekta AB ADR.
September 2026
The U.S. cell therapy manufacturing market was worth USD 1.97 billion in 2026, with key U.S. cell therapy manufacturing market players including Merck KGaA, Thermo Fisher Scientific, Catalent, Inc.
September 2026
The U.S. drug discovery market generated USD 28.66 billion in 2026, with prominent U.S. drug discovery market companies including Johnson and Johnson, Pfizer Inc., Merck and Co.
September 2026
The U.S. DNA synthesis market generated USD 2.30 billion in 2026, with prominent U.S. DNA synthesis market companies including LGC Biosearch Technologie, Bioneer Corporation, Thermo Fisher Scientific, Inc.
September 2026
The U.S. cardiovascular drugs market was valued at USD 29.25 billion in 2026, with leading companies including Bristol-Myers Squibb, Bayer AG, Pfizer Inc.
September 2026
The U.S. CAR T-cell therapy market size stood at USD 2,684.84 million in 2026, with major U.S. CAR T-cell therapy market companies including Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences, Inc.
September 2026
The AI in cancer immunotherapy drugs market reached USD 3.52 billion in 2026, featuring leading AI in cancer immunotherapy drugs market companies such as Exscientia, Insilico Medicine.
September 2026
The U.S. radiopharmaceutical therapies market size is estimated to hit around USD 7.70 billion by 2035 increasing from USD 1.92 billion in 2025, with a CAGR of 14.9%%.
September 2026
The U.S. pain management drugs market reached USD 33.84 billion in 2026, with key U.S. pain management drugs companies including abbott, Pfizer, teva pharmaceutical, endo international, depomed, merck.
September 2026
The U.S. non-invasive aesthetic treatment market size totalled USD 8.72 billion in 2026, with major U.S. non-invasive aesthetic treatment market players including galderma sa, allergen, alma lasers, lumenis, merz pharma.
July 2026
The global general anesthesia drugs market size was calculated at USD 5.60 billion in 2025 and is projected to surpass around USD 8.06 billion by 2035, with a CAGR of 3.71%.
July 2026
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
June 2026
The U.S. multiple sclerosis drugs market size is estimated to hit around USD 18.43 billion by 2035 increasing from USD 9.11 billion in 2026, with a CAGR of 8.12%.
June 2026
The U.S. stem cell therapy market size reached USD 6.75 billion in 2025 and is projected to hit around USD 21.31 billion by 2035 with a remarkeble CAGR of 12.18%.
February 2026
The U.S. dental anesthesia market size was exhibited at USD 348.46 million in 2025 and is predicted to be worth around USD 554.64 million by 2035 with a CAGR of 4.76%.
February 2026
The global anthelmintic drugs market size was evaluated at USD 4.06 billion in 2025 and is predicted to hit around USD 9.01 billion by 2035, growing at a CAGR of 8.30%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com